BCL2 and neoplasm: The expression analysis (Figure 5A) showed that ESR1 had no expression difference between normal and tumor groups; BCL2 expression was lower in tumor group (P < 0.001); while AKT1, CCND1, and HIF1A expressions were higher in tumor group compared with those in normal group (all P < 0.001).